VFA
COLL icon

Virtus Fund Advisers’s Collegium Pharmaceutical COLL Stock Holding History

Virtus Fund Advisers’s Portfolio COLL Stock Details COLL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		$69.3K Buy
2,419
+565
+30% +$18.7K 0.22% 41
2024
Q3 		$71.6K Buy
+1,854
New +$66.1K 0.29% 43

Other funds holding COLL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

Virtus Fund Advisers's COLL Position: Q4 2024 in Review

Virtus Fund Advisers increased its Collegium Pharmaceutical (COLL) stake by 30% in Q4 2024, buying an estimated $18.7K and bringing the position to 2,419 shares worth $69.3K. The position accounts for 0.22% of the portfolio, ranked #41.

Virtus Fund Advisers first reported a position in COLL in Q3 2024 and has held it in 2 quarters since. The position peaked at $71.6K in Q3 2024. 238 funds tracked by Wall St. Rank hold COLL as of Q4 2024.

  • Virtus Fund Advisers held 2,419 shares of Collegium Pharmaceutical worth $69.3K as of Q4 2024.
  • Virtus Fund Advisers bought 565 Collegium Pharmaceutical shares in Q4 2024, an estimated $18.7K.
  • Collegium Pharmaceutical made up 0.22% of Virtus Fund Advisers's portfolio in Q4 2024, its #41 holding.
  • Virtus Fund Advisers first reported a position in Collegium Pharmaceutical in Q3 2024 and has held it in 2 quarters since.
  • Virtus Fund Advisers's Collegium Pharmaceutical position peaked at $71.6K in Q3 2024.
  • 238 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q4 2024.

Based on Virtus Fund Advisers's 13F filing for Q4 2024, filed 14 Feb 2025.